Nuveen’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Nuveen's RXST Position: Q1 2026 in Review
Nuveen reduced its RxSight (RXST) stake by 87% in Q1 2026, selling an estimated $3.83M and leaving 70,887 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #2895.
Nuveen first reported a position in RXST in Q1 2022 and has held it in 17 quarters since. The position peaked at $38.4M in Q1 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Nuveen held 70,887 shares of RxSight worth $437K as of Q1 2026.
- Nuveen sold 460,843 RxSight shares in Q1 2026, an estimated $3.83M.
- RxSight made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2895 holding.
- Nuveen first reported a position in RxSight in Q1 2022 and has held it in 17 quarters since.
- Nuveen's RxSight position peaked at $38.4M in Q1 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.